Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 9/20 | 0.67 |
| ▸ | CDK2 | P24941 | 12/20 | 0.65 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.58 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12953185 | 0.90 | GSK3B (0.67) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL13118479 | 0.81 | GSK3B (1.00) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL13146085 | 0.80 | GSK3B (0.52) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL12953263 | 0.80 | CDK2 (0.65) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL12954168 | 0.80 | GSK3B (0.69) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL13146191 | 0.79 | GSK3B (0.84) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL12953328 | 0.79 | CDK2 (1.00) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL13117841 | 0.78 | GSK3B (0.72) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL12953158 | 0.78 | CDK2 (0.83) | GSK3BCDK2CCNA2CCNA1CCNE1 | |
| SCHEMBL12954052 | 0.78 | CDK2 (0.62) | GSK3BCDK2CCNA2CCNA1CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007044449-A2 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |